Serum Neurofilament Identifies Patients With Multiple Sclerosis With Severe Focal Axonal Damage in a 6-Year Longitudinal Cohort
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received June 6, 2022
- Accepted in final form September 16, 2022
- First Published November 21, 2022.
Author Disclosures
- Falk Steffen, MD*,
- Timo Uphaus, MD*,
- Nina Ripfel, MD,
- Vinzenz Fleischer, MD,
- Muriel Schraad, MD,
- Gabriel Gonzalez-Escamilla, PhD,
- Sinah Engel, MD,
- Sergiu Groppa, MD,
- Frauke Zipp, MD† and
- Stefan Bittner, MD, PhD†
- Falk Steffen, MD*,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Timo Uphaus, MD*,
None
NONE
(1) Merck Serono,speaker honoraria (2) Pfizer, travel honoraria.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Else Kröner Memorial Stipendium
NONE
NONE
NONE
NONE
NONE
NONE
- Nina Ripfel, MD,
None
NONE
(1) Merck Serono,speaker honoraria (2) Pfizer, travel honoraria.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Else Kröner Memorial Stipendium
NONE
NONE
NONE
NONE
NONE
NONE
- Vinzenz Fleischer, MD,
None
NONE
(1) Merck Serono,speaker honoraria (2) Pfizer, travel honoraria.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Else Kröner Memorial Stipendium
NONE
NONE
NONE
NONE
NONE
NONE
- Muriel Schraad, MD,
None
NONE
(1) Merck Serono,speaker honoraria (2) Pfizer, travel honoraria.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Else Kröner Memorial Stipendium
NONE
NONE
NONE
NONE
NONE
NONE
- Gabriel Gonzalez-Escamilla, PhD,
None
NONE
(1) Merck Serono,speaker honoraria (2) Pfizer, travel honoraria.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Else Kröner Memorial Stipendium
NONE
NONE
NONE
NONE
NONE
NONE
- Sinah Engel, MD,
None
NONE
(1) Merck Serono,speaker honoraria (2) Pfizer, travel honoraria.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Else Kröner Memorial Stipendium
NONE
NONE
NONE
NONE
NONE
NONE
- Sergiu Groppa, MD,
None
NONE
None
Nature scientific reports editor 2018
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Frauke Zipp, MD† and
(1) Novartis (2) Octapharma (3) Merck Serono (4) ONO Pharma (5) Genzyme (7) Celgene (8) Roche (9) Sanofi-Aventis
NONE
(1) Novartis (2) Octapharma (3) Merck Serono (4) ONO Pharma (5) Genzyme (7) Celgene (8) Roche (9) Sanofi-Aventis
(1) Brain, Associate Editor, 2021-2022(2) Science Translational Medicine, Advisor, 2021-
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) Genzyme
(1) DFG CRC-TRR 128, Co-Spokesperson/Spokesperson,2012-2024 (2) DFG CRC1080, PI, 2013-2024 (3) DFG CRC1292, PI, 2018-2025(4) BMBF HaltMS, PI, 2020-2023
NONE
(1) Progressive MS Alliance, BRAVEinMS
NONE
NONE
NONE
NONE
NONE
NONE
- Stefan Bittner, MD, PhD†
None
NONE
S. B. has received funding for honoraria from Biogen Idec, BMS, Merck Serono, Novartis, Roche, Sanofi Genzyme and TEVA.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) German Research Council (DFG, CRC-TR-128)
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- From the Department of Neurology, Focus Program Translational Neuroscience (FTN) and Immunotherapy (FZI), Rhine Main Neuroscience Network (rmn2), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
- Correspondence
Dr. Bittner bittner{at}uni-mainz.de
Article usage
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Nicole Sur and Dr. Mausaminben Hathidara
► Watch
Related Articles
- No related articles found.